Blanchard Cheryl R
SEC CIK 1326530 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANIK | Anika Therapeutics, Inc. | Pres, CEO, Dir | 270.9K | $207.1K | — | 22 | 2022-03-09 | 2026-03-14 |
Most active insiders at ANIK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Griffin Stephen D. | Pres, CEO, Dir | $149.9K | — |
| 2 | HENNEMAN JOHN B III | Dir | $73.3K | — |
| 3 | Fischetti Gary P | Dir | $41.1K | — |
| 4 | Richard Stephen | Dir | — | — |
| 5 | Colleran David | EVP, GC, Corp Sec | — | — |
| 6 | Capper Joseph H | Dir | — | — |
| 7 | McLeod Ian | SVP, CAO, Treas | — | — |
| 8 | Blanchard Cheryl R | Dir | — | — |
| 9 | CONLEY SHERYL L | Dir | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-17 | 2026-03-14+ | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Dir | M - OptEx | — | +49.6K | 270.9K | +22% | — |
| D | 2026-03-17 | 2026-03-14 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Dir | A - Grant | $0.00 | +24.5K | 260.5K | +10% | $0 |
| DM | 2026-03-17 | 2026-03-14+ | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Dir | F - Tax | $14.20 | -26.8K | 245.8K | -10% | -$381.0K |
| D | 2026-03-11 | 2026-03-09 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Dir | F - Tax | $14.96 | -5,871 | 211.4K | -3% | -$87.8K |
| D | 2026-03-11 | 2026-03-09 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Dir | M - OptEx | — | +20.0K | 217.3K | +10% | — |
| D | 2025-03-18 | 2025-03-17 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Pres, CEO, Dir | M - OptEx | $0.00 | +25.1K | 209.5K | +14% | $0 |
| D | 2025-03-18 | 2025-03-17 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Pres, CEO, Dir | F - Tax | $15.91 | -12.2K | 197.3K | -6% | -$193.3K |
| D | 2025-03-13 | 2025-03-11 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Pres, CEO, Dir | F - Tax | $16.79 | -12.7K | 184.3K | -6% | -$212.8K |
| D | 2025-03-13 | 2025-03-11 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Pres, CEO, Dir | M - OptEx | $0.00 | +30.1K | 197.0K | +18% | $0 |
| D | 2025-03-11 | 2025-03-10 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Pres, CEO, Dir | F - Tax | $16.62 | -5,871 | 167.0K | -3% | -$97.6K |
| D | 2025-03-11 | 2025-03-10 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Pres, CEO, Dir | M - OptEx | $0.00 | +20.0K | 172.8K | +13% | $0 |
| DM | 2024-03-12 | 2024-03-11 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Pres, CEO, Dir | F - Tax | $25.61 | -28.0K | 151.7K | -16% | -$716.6K |
| DM | 2024-03-12 | 2024-03-11 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Pres, CEO, Dir | M - OptEx | $0.00 | +64.5K | 166.2K | +63% | $0 |
| D | 2023-04-28 | 2023-04-26 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Pres, CEO, Dir | M - OptEx | $0.00 | +24.6K | 125.2K | +24% | $0 |
| D | 2023-04-28 | 2023-04-26 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Pres, CEO, Dir | F - Tax | $26.34 | -10.9K | 114.3K | -9% | -$287.1K |
| D | 2023-03-14 | 2023-03-10 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Pres, CEO, Dir | F - Tax | $26.10 | -13.2K | 100.6K | -12% | -$344.8K |
| D | 2023-03-14 | 2023-03-10 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Pres, CEO, Dir | M - OptEx | $0.00 | +30.1K | 113.8K | +36% | $0 |
| D | 2023-03-10 | 2023-03-09 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Pres, CEO, Dir | F - Tax | $26.91 | -4,232 | 83.7K | -5% | -$113.9K |
| D | 2023-03-10 | 2023-03-09 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Pres, CEO, Dir | M - OptEx | $0.00 | +14.4K | 88.0K | +20% | $0 |
| D | 2022-04-28 | 2022-04-26 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Pres, CEO, Dir | M - OptEx | $0.00 | +24.6K | 72.8K | +51% | $0 |
| M | 2022-03-14 | 2022-03-11 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Pres, CEO, Dir | P - Purchase | $25.57 | +8,100 | 60.0K | +16% | +$207.1K |
| D | 2022-03-11 | 2022-03-09 | ANIK | Anika Therapeutics, Inc. | Blanchard Cheryl R | Pres, CEO, Dir | M - OptEx | $0.00 | +14.4K | 51.9K | +38% | $0 |
Purchase Sale Sale after option exercise All abbreviations